Literature DB >> 28760485

Phospholipid class-specific brain enrichment in response to lysophosphatidylcholine docosahexaenoic acid infusion.

Raphaël Chouinard-Watkins1, Chuck T Chen2, Adam H Metherel2, R J Scott Lacombe2, Frank Thies3, Mojgan Masoodi4, Richard P Bazinet2.   

Abstract

Recent studies suggest that at least two pools of plasma docosahexaenoic acid (DHA) can supply the brain: non-esterified DHA (NE-DHA) and lysophosphatidylcholine (lysoPtdCho)-DHA. In contrast to NE-DHA, brain uptake of lysoPtdCho-DHA appears to be mediated by a specific transporter, but whether both forms of DHA supply undergo the same metabolic fate, particularly with regards to enrichment of specific phospholipid (PL) subclasses, remains to be determined. This study aimed to evaluate brain uptake of NE-DHA and lysoPtdCho-DHA into brain PL classes. Fifteen-week-old rats were infused intravenously with radiolabelled NE-14C-DHA or lysoPtdCho-14C-DHA (n=4/group) over five mins to achieve a steady-state plasma level. PLs were extracted from the brain and separated by thin layer chromatography and radioactivity was quantified by liquid scintillation counting. The net rate of entry of lysoPtdCho-DHA into the brain was between 59% and 86% lower than the net rate of entry of NE-DHA, depending on the PL class. The proportion of total PL radioactivity in the lysoPtdCho-14C-DHA group compared to the NE-14C-DHA group was significantly higher in choline glycerophospholipids (ChoGpl) (48% vs 28%, respectively) but lower in ethanolamine glycerophospholipids (EtnGpl) (32% vs 46%, respectively). In both groups, radioactivity was disproportionally high in phosphatidylinositol and ChoGpl but low in phosphatidylserine and EtnGpl compared to the corresponding DHA pool size. This suggests that DHA undergoes extensive PL remodeling after entry into the brain.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brain; Docosahexaenoic acid; Lysophosphatidylcholine; Phosphatidylcholine; Phosphatidylethanolamine; Phosphatidylserine

Mesh:

Substances:

Year:  2017        PMID: 28760485     DOI: 10.1016/j.bbalip.2017.07.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Biol Lipids        ISSN: 1388-1981            Impact factor:   4.698


  6 in total

1.  ACSL6 is critical for maintaining brain DHA levels.

Authors:  Raphaël Chouinard-Watkins; Richard P Bazinet
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-16       Impact factor: 11.205

2.  Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease.

Authors:  Richard D Semba
Journal:  Adv Nutr       Date:  2020-07-01       Impact factor: 8.701

3.  Turnover of brain DHA in mice is accurately determined by tracer-free natural abundance carbon isotope ratio analysis.

Authors:  R J Scott Lacombe; Chi-Chiu Lee; Richard P Bazinet
Journal:  J Lipid Res       Date:  2019-11-11       Impact factor: 5.922

Review 4.  Towards an Optimized Fetal DHA Accretion: Differences on Maternal DHA Supplementation Using Phospholipids vs. Triglycerides during Pregnancy in Different Models.

Authors:  Antonio Gázquez; Elvira Larqué
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

Review 5.  Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases.

Authors:  Mayssa Hachem; Houda Nacir
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

6.  Docosahexaenoic Acid (DHA) Bioavailability in Humans after Oral Intake of DHA-Containing Triacylglycerol or the Structured Phospholipid AceDoPC®.

Authors:  Mayssa Hachem; Houda Nacir; Madeleine Picq; Mounir Belkouch; Nathalie Bernoud-Hubac; Anthony Windust; Laure Meiller; Valerie Sauvinet; Nathalie Feugier; Stephanie Lambert-Porcheron; Martine Laville; Michel Lagarde
Journal:  Nutrients       Date:  2020-01-18       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.